The prolyl-isomerase PIN1 is essential for nuclear Lamin-B structure and function and protects heterochromatin under mechanical stress.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
14 09 2021
Historique:
received: 16 02 2021
revised: 29 06 2021
accepted: 19 08 2021
entrez: 15 9 2021
pubmed: 16 9 2021
medline: 16 2 2022
Statut: ppublish

Résumé

Chromatin organization plays a crucial role in tissue homeostasis. Heterochromatin relaxation and consequent unscheduled mobilization of transposable elements (TEs) are emerging as key contributors of aging and aging-related pathologies, including Alzheimer's disease (AD) and cancer. However, the mechanisms governing heterochromatin maintenance or its relaxation in pathological conditions remain poorly understood. Here we show that PIN1, the only phosphorylation-specific cis/trans prolyl isomerase, whose loss is associated with premature aging and AD, is essential to preserve heterochromatin. We demonstrate that this PIN1 function is conserved from Drosophila to humans and prevents TE mobilization-dependent neurodegeneration and cognitive defects. Mechanistically, PIN1 maintains nuclear type-B Lamin structure and anchoring function for heterochromatin protein 1α (HP1α). This mechanism prevents nuclear envelope alterations and heterochromatin relaxation under mechanical stress, which is a key contributor to aging-related pathologies.

Identifiants

pubmed: 34525372
pii: S2211-1247(21)01141-4
doi: 10.1016/j.celrep.2021.109694
pii:
doi:

Substances chimiques

DNA Transposable Elements 0
Drosophila Proteins 0
Heterochromatin 0
Lamin Type B 0
NIMA-Interacting Peptidylprolyl Isomerase 0
RNA, Small Interfering 0
Chromobox Protein Homolog 5 107283-02-3
Peptidylprolyl Isomerase EC 5.2.1.8
dod protein, Drosophila EC 5.2.1.8

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109694

Subventions

Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG032990
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG046139
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG018023
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG017216
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG015819
Pays : United States

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Francesco Napoletano (F)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy; Department of Life Sciences (DSV), University of Trieste, 34127 Trieste, Italy. Electronic address: fnapoletano@units.it.

Gloria Ferrari Bravo (G)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy; Department of Life Sciences (DSV), University of Trieste, 34127 Trieste, Italy.

Ilaria Anna Pia Voto (IAP)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy.

Aurora Santin (A)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy.

Lucia Celora (L)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy.

Elena Campaner (E)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy; Department of Life Sciences (DSV), University of Trieste, 34127 Trieste, Italy.

Clara Dezi (C)

Department of Life Sciences (DSV), University of Trieste, 34127 Trieste, Italy.

Arianna Bertossi (A)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy; Department of Life Sciences (DSV), University of Trieste, 34127 Trieste, Italy.

Elena Valentino (E)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy.

Mariangela Santorsola (M)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy; Department of Life Sciences (DSV), University of Trieste, 34127 Trieste, Italy.

Alessandra Rustighi (A)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy; Department of Life Sciences (DSV), University of Trieste, 34127 Trieste, Italy.

Valentina Fajner (V)

FIRC Institute of Molecular Oncology (IFOM), 20139 Milan, Italy.

Elena Maspero (E)

FIRC Institute of Molecular Oncology (IFOM), 20139 Milan, Italy.

Federico Ansaloni (F)

Area of Neuroscience, International School for Advanced Studies (SISSA), 34146 Trieste, Italy.

Valeria Cancila (V)

Tumor Immunology Unit, Department of Health Science, Human Pathology Section, School of Medicine, University of Palermo, 90133 Palermo, Italy.

Cesare Fabio Valenti (CF)

Tumor Immunology Unit, Department of Health Science, Human Pathology Section, School of Medicine, University of Palermo, 90133 Palermo, Italy.

Manuela Santo (M)

Area of Neuroscience, International School for Advanced Studies (SISSA), 34146 Trieste, Italy.

Osvaldo Basilio Artimagnella (OB)

Area of Neuroscience, International School for Advanced Studies (SISSA), 34146 Trieste, Italy.

Sara Finaurini (S)

Area of Neuroscience, International School for Advanced Studies (SISSA), 34146 Trieste, Italy.

Ubaldo Gioia (U)

FIRC Institute of Molecular Oncology (IFOM), 20139 Milan, Italy.

Simona Polo (S)

FIRC Institute of Molecular Oncology (IFOM), 20139 Milan, Italy.

Remo Sanges (R)

Area of Neuroscience, International School for Advanced Studies (SISSA), 34146 Trieste, Italy.

Claudio Tripodo (C)

FIRC Institute of Molecular Oncology (IFOM), 20139 Milan, Italy; Tumor Immunology Unit, Department of Health Science, Human Pathology Section, School of Medicine, University of Palermo, 90133 Palermo, Italy.

Antonello Mallamaci (A)

Area of Neuroscience, International School for Advanced Studies (SISSA), 34146 Trieste, Italy.

Stefano Gustincich (S)

Area of Neuroscience, International School for Advanced Studies (SISSA), 34146 Trieste, Italy; Central RNA Laboratory, Italian Institute of Technology, 16163 Genova, Italy.

Fabrizio d'Adda di Fagagna (F)

FIRC Institute of Molecular Oncology (IFOM), 20139 Milan, Italy; Institute of Molecular Genetics, National Research Institute (CNR), Pavia, Italy.

Fiamma Mantovani (F)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy; Department of Life Sciences (DSV), University of Trieste, 34127 Trieste, Italy.

Valeria Specchia (V)

Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, 73100 Lecce, Italy.

Giannino Del Sal (G)

Laboratorio Nazionale CIB (LNCIB), Area Science Park, Padriciano 99, 34149 Trieste, Italy; Department of Life Sciences (DSV), University of Trieste, 34127 Trieste, Italy; FIRC Institute of Molecular Oncology (IFOM), 20139 Milan, Italy. Electronic address: gdelsal@units.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH